ABUS icon

Arbutus Biopharma

59 hedge funds and large institutions have $67.4M invested in Arbutus Biopharma in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+4
Holders Change %
+7.27%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
15
Increased
10
Reduced
18
Closed
11
Calls
$501K
Puts
Net Calls
+$501K
Net Calls Change
+$509K
Name Holding Trade Value Shares
Change
Shares
Change %
FHA
51
Flagship Harbor Advisors
Massachusetts
$1K
AG
52
Advisor Group
Arizona
$1K
BNP Paribas Financial Markets
53
BNP Paribas Financial Markets
France
$195 -$10.8K -3,892 -98%
SFM
54
Sphera Funds Management
Israel
-$763K -500,000 Closed
Renaissance Technologies
55
Renaissance Technologies
New York
-$257K -168,312 Closed
JPMorgan Chase & Co
56
JPMorgan Chase & Co
New York
-$145K -95,146 Closed
SG Americas Securities
57
SG Americas Securities
New York
-$54K -35,701 Closed
LP
58
LMR Partners
United Kingdom
-$44K -29,104 Closed
Walleye Trading
59
Walleye Trading
New York
-$35K -22,658 Closed
Walleye Capital
60
Walleye Capital
New York
-$34K -22,572 Closed
ProShare Advisors
61
ProShare Advisors
Maryland
-$23K -15,394 Closed
MAM
62
Meeder Asset Management
Ohio
-$9K -5,716 Closed
Group One Trading
63
Group One Trading
Illinois
-$5K -3,140 Closed